LAURAS AS has a total of 42 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United Kingdom, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are REPLICOR INC, AXCAN PHARMA INC and GRAY LLOYD S.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 6 | |
#2 | Canada | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | Australia | 3 | |
#6 | China | 3 | |
#7 | Norway | 3 | |
#8 | New Zealand | 3 | |
#9 | United States | 3 | |
#10 | African Regional Industrial Property Organization | 1 | |
#11 | Czechia | 1 | |
#12 | Hong Kong | 1 | |
#13 | Hungary | 1 | |
#14 | Japan | 1 | |
#15 | African Intellectual Property Organization | 1 | |
#16 | Poland | 1 | |
#17 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Sugars | |
#5 | Fermentation | |
#6 | Unspecified technologies | |
#7 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Tasken Kjetil | 25 |
#2 | Hansson Vidar | 25 |
#3 | Aandahl Einar Martin | 18 |
#4 | Aukrust Pal | 14 |
#5 | Klaveness Jo | 13 |
#6 | Moutschen Michel | 12 |
#7 | Froland Stig S | 11 |
#8 | Rahmouni-Piette Souad | 9 |
#9 | Johansson Christian Carl | 8 |
#10 | Altman Amnon | 6 |
Publication | Filing date | Title |
---|---|---|
GB0618235D0 | Process | |
WO2005060996A2 | Method of altering the pka type i signalling pathway | |
GB0413726D0 | Compounds | |
GB0413718D0 | Novel compounds | |
GB0329869D0 | Inhibitors | |
PL359556A1 | Method - use of cox-2 inhibitors for preventing immunodeficiency | |
GB0109648D0 | Method | |
GB0017908D0 | Method | |
US7192932B1 | Use of immunomodulating agents | |
CA2333159A1 | Method | |
AU7086598A | Use of immunomodulating agents |